Topical interventions for genital lichen sclerosus

Area of Science:

• Dermatology
• Clinical Trials
• Pharmacology

Background:

• Lichen sclerosus is a chronic inflammatory skin condition affecting the genital area, potentially causing severe damage and increasing cancer risk.
• It primarily impacts adult women but can affect men and children, leading to itching, soreness, and scarring.

Purpose of the Study:

• To evaluate the effectiveness of topical treatments for genital lichen sclerosus.
• To identify and report adverse effects associated with these interventions.

Main Methods:

• Conducted a systematic review of randomized controlled trials (RCTs) of topical interventions for genital lichen sclerosus.
• Searched multiple databases up to September 2011 and included 7 RCTs with 249 participants.

Main Results:

• Clobetasol propionate 0.05% demonstrated significant improvement in symptoms and global improvement compared to placebo.
• Mometasone furoate 0.05% showed significant improvement in phimosis.
• No significant adverse effects were reported for corticosteroids versus placebo; topical testosterone worsened symptoms in one study.

Conclusions:

• Limited evidence supports the efficacy of clobetasol propionate, mometasone furoate, and pimecrolimus for genital lichen sclerosus.
• Further RCTs are required to optimize corticosteroid regimens, explore other interventions, and evaluate long-term outcomes, including cancer risk reduction and quality of life.